RALEIGH, N.C., Nov. 5, 2013 (GLOBE NEWSWIRE) -- LipoScience, Inc. (Nasdaq:LPDX), a diagnostic company pioneering a new field of personalized nuclear magnetic resonance (NMR) diagnostics to advance the quality of patient care in cardiovascular, metabolic and other diseases, today announced its financial results for the third quarter ended September 30, 2013.
Help employers find you! Check out all the jobs and post your resume.
